Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 20Stomach Neoplasms 2Inflammatory Breast Neoplasms 2Rectal Neoplasms 1Neoplastic Cells, Circulating 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Invasive Breast Cancer 1HER2 Positive Breast Cancer 1Elderly Metastatic Breast Cancer Population 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Breast Neoplasms, Male 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Cancer 1

Interventions

Trastuzumab 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplastic Cells, Circulating × Trastuzumab × Clear all
NCT01548677 2019-03-13

TREAT-CTC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
1,317 enrolled
Breast

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡